| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,508 |
12,846 |
$2.61M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,783 |
5,807 |
$1.08M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,753 |
4,664 |
$728K |
| 71045 |
Radiologic examination, chest; single view |
3,330 |
2,726 |
$439K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,540 |
3,713 |
$234K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,059 |
2,492 |
$178K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,742 |
1,526 |
$138K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,778 |
2,250 |
$105K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
602 |
192 |
$104K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,689 |
1,389 |
$68K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,489 |
1,279 |
$64K |
| 80053 |
Comprehensive metabolic panel |
9,082 |
7,563 |
$58K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,765 |
8,907 |
$51K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
227 |
213 |
$50K |
| 71046 |
Radiologic examination, chest; 2 views |
471 |
371 |
$38K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
967 |
895 |
$36K |
| 87503 |
|
1,359 |
1,228 |
$33K |
| 36415 |
Collection of venous blood by venipuncture |
8,603 |
7,041 |
$32K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
70 |
66 |
$29K |
| 70450 |
Computed tomography, head or brain; without contrast material |
246 |
218 |
$27K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
800 |
728 |
$23K |
| 84484 |
|
3,108 |
2,137 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
564 |
439 |
$11K |
| 83690 |
|
1,967 |
1,666 |
$8K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
127 |
111 |
$8K |
| 81025 |
|
1,150 |
1,007 |
$8K |
| 83735 |
|
1,870 |
1,568 |
$7K |
| 81001 |
|
2,334 |
1,985 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,466 |
1,137 |
$5K |
| 83605 |
|
494 |
354 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
69 |
55 |
$2K |
| 83880 |
|
134 |
98 |
$2K |
| 81003 |
|
1,277 |
989 |
$2K |
| 87400 |
|
175 |
78 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16 |
16 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
161 |
151 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
15 |
12 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
432 |
303 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
307 |
228 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
136 |
59 |
$927.75 |
| 87040 |
|
164 |
69 |
$842.10 |
| 82550 |
|
131 |
117 |
$416.26 |
| 82553 |
|
115 |
104 |
$380.79 |
| 80051 |
|
81 |
75 |
$295.17 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
77 |
68 |
$280.15 |
| 82565 |
|
98 |
87 |
$270.53 |
| 84443 |
Thyroid stimulating hormone (TSH) |
28 |
28 |
$252.00 |
| 84520 |
|
98 |
87 |
$208.51 |
| 82947 |
|
98 |
87 |
$207.43 |
| 87420 |
|
14 |
13 |
$194.74 |
| 85610 |
|
47 |
42 |
$105.30 |
| 80076 |
|
31 |
24 |
$69.71 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
21 |
12 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
72 |
39 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
65 |
36 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
33 |
15 |
$0.00 |